Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
- Conditions
- Faecal IncontinenceProstate Cancer
- Registration Number
- NCT04262609
- Lead Sponsor
- Consorci Sanitari de Terrassa
- Brief Summary
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
- Detailed Description
The investigators know that high doses of irradiation in the anal sphincter are associated with more chronic fecal leaks in survivors irradiated by normofractionated radiotherapy prostate cancer.
The safe dose of irradiation of the anal sphincter with radiotherapy modern techniques (volumetric modulated arc therapy with moderately hypofracctionation) is unknown.
Urgency and faecal incontinence greatly affects the quality of life of these patients.
Therefore, it is interesting to implement strategies to protect the anatomical structures involved in fecal continence.
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with modern moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
The investigators also want to evaluate the quality of life of these patients
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 200
- Prostate cancer survivors treated in our department by hypofractionated radiotherapy
- Relapse of prostate cancer
- Other active cancer
- Mental disorder
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method faecal incontinence after prostate radiation therapy change 5 years after completion of radiotherapy grade of faecal incontinence in prostate cancer survivors
- Secondary Outcome Measures
Name Time Method Quality of life after prostate radiation therapy 5 years after completion of radiotherapy Quality of life in prostate cancer survivors comparing continents patients and incontinents patients
Trial Locations
- Locations (1)
Consorci Sanitari de Terrassa
🇪🇸Terrassa, Catalonia, Spain